| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NovaBay Pharmaceuticals, Inc. | 10%+ Owner | Common Stock | 56.8M | $74.2M | $1.31 | Oct 21, 2025 | Direct |
| NovaBay Pharmaceuticals, Inc. | 10%+ Owner | Pre-Funded Warrants (Right to Buy) | 2.7M | Oct 16, 2025 | Direct | ||
| NovaBay Pharmaceuticals, Inc. | 10%+ Owner | Series D Non-Voting Convertible Preferred Stock | 221K | Oct 16, 2025 | Direct | ||
| NovaBay Pharmaceuticals, Inc. | 10%+ Owner | Series E Non-Voting Convertible Preferred Stock | 134K | Oct 16, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NBY | NovaBay Pharmaceuticals, Inc. | Oct 16, 2025 | 2 | $0 | 4 | Nov 3, 2025 | 10%+ Owner |
| NBY | NovaBay Pharmaceuticals, Inc. | Oct 16, 2025 | 2 | $0 | 4/A | Oct 22, 2025 | 10%+ Owner |
| NBY | NovaBay Pharmaceuticals, Inc. | Oct 9, 2025 | 0 | $0 | 3/A | Oct 22, 2025 | 10%+ Owner |